Are you Dr. Ogbuagu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 York St
New Haven, CT 06510Phone+1 203-688-6959- Is this information wrong?
Summary
- Dr. Onyema Ogbuagu, MD is an infectious disease specialist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and New York. He is affiliated with Yale-New Haven Hospital and MidState Medical Center.
Education & Training
- Yale-New Haven Medical CenterFellowship, Infectious Disease, 2010 - 2012
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2010
- University of Calabar Faculty of MedicineClass of 2003
Certifications & Licensure
- CT State Medical License 2011 - 2024
- NY State Medical License 2010 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study.Strong, S., Oldfield, B., van den Berg, J., Cole, C., Biegacki, E., Virata, M., Chan, P., Ogbuagu, O., Edelman, E.> ;Preventive Medicine Reports. 2024 Jan 1
- Pharmacokinetic evaluation of sofosbuvir/velpatasvir for the treatment of Chronic Hepatitis C in pediatrics aged 3 and older.Tuan, J., Okoli, A., Ogbuagu, O.> ;Expert Opinion on Drug Metabolism & Toxicology. 2023 Dec 1
- Acute cytomegalovirus proctitis and epididymitis acquired via sexual transmission in an immunocompetent patient: a case report.Deborah M Oyeyemi, Elizabeth Chan, Annika Belzer, Onyema Ogbuagu, Heidi Zapata, Jessica J Tuan, Montano, M.> ;Journal of Medical Case Reports. 2023 Nov 10
- Join now to see all
Authored Content
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Join now to see all
Press Mentions
- Fact Check: COVID-19 Vaccination Decreases Chances of Hospitalization, Contrary to Post's ImplicationJanuary 24th, 2023
- New Clinical Data Support the Sustained Efficacy of Long-Acting Lenacapavir, Gilead’s Investigational HIV-1 Capsid InhibitorFebruary 16th, 2022
- Faces of the Unvaccinated: Nurse Contracts COVID for a Second Time After Refusing to Get VaccinatedFebruary 4th, 2022
- Join now to see all
Hospital Affiliations
- Yale-New Haven HospitalNew Haven, Connecticut
- MidState Medical CenterMeriden, Connecticut